pan-tumor

AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
ASCO: Is another pan-tumor drug on the horizon? Johnson & Johnson thinks Balversa could be it
Fierce Pharma
Fri, 05/27/22 - 10:19 am
ASCO 2022
JNJ
Janssen
pan-tumor
Balversa